Clinical Outcome Following the Use of Inadequate Solutions for Continuous Veno-Venous Hemodiofiltration

被引:4
作者
Celik, Jale Bengi [1 ]
Topal, Ahmet [1 ]
Kartal, Elmas [1 ]
Yosunkaya, Alper [1 ]
机构
[1] Selcuk Univ, Meram Med Fac, Dept Anesthesiol, TR-42080 Konya, Turkey
关键词
dialysate; continuous renal replacement therapy; metabolic disturbances;
D O I
10.1080/08860220802422028
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Backgrounds. A short time ago, commercially available diafiltration and replacement fluids could be found o n the hospital in Turkey. Instead, peritoneal dialysis solution (PDS) for continue veno-venous hemodiafiltration (CVVHDF) therapy and normal saline as replacement fluid are used. In this retrospective study, we investigated the effects of PDS and bicarbonate-buffered hemofiltration solution (Bic-HFS). Methods. We did a retrospective chart review of 24 patients treated with continue renal replacement therapy (CRRT) between January 2004 and February 2008. Peritoneal dialysis solution (PDS) was used in 14 patients, and bicarbonate-buffered hemodialysis solution (bic-HFS) was used in 10 patients. Results. Demographic data, laboratory findings, and mortality rate were similar both groups. Blood glucose and lactate levels were higher in the PD group than the bic-HFS group (p 0.05). Hyperglycemia occurred more frequent in the PDS group than in the bic-HFS group (64% versus 30%, respectively; p 0.05). Metabolic acidosis occurred in eight patients (57%) in the PDS group and three patients (30%) in the bic-HFS group (p 0.05). Hypotension was higher in the PDS group (10, 71%) than in the bic-HFS group (3, 30%; p 0.05). Conclusion. Using PDS fluid as dialysate for CVVHDF therapy is not a preferable solution because of the metabolic disturbances that it can cause.
引用
收藏
页码:959 / 964
页数:6
相关论文
共 20 条
[1]   Effects of bicarbonate- and lactate-buffered replacement fluids on cardiovascular outcome in CVVH patients [J].
Barenbrock, M ;
Hausberg, M ;
Matzkies, F ;
de la Motte, S ;
Schaefer, RM .
KIDNEY INTERNATIONAL, 2000, 58 (04) :1751-1757
[2]   Copper, selenium, zinc, and thiamine balances during continuous venovenous hemodiafiltration in critically ill patients [J].
Berger, MM ;
Shenkin, A ;
Revelly, JP ;
Roberts, E ;
Cayeux, MC ;
Baines, M ;
Chioléro, RL .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2004, 80 (02) :410-416
[3]   Effect of bicarbonate and lactate buffer on glucose and lactate metabolism during hemodiafiltration in patients with multiple organ failure [J].
Bollmann, MD ;
Revelly, JP ;
Tappy, L ;
Berger, MM ;
Schaller, MD ;
Cayeux, MC ;
Martinez, A ;
Chioléro, RL .
INTENSIVE CARE MEDICINE, 2004, 30 (06) :1103-1110
[4]   HYPERLACTATEMIA AND METABOLIC-ACIDOSIS DURING HEMOFILTRATION USING LACTATE-BUFFERED FLUIDS [J].
DAVENPORT, A ;
WILL, EJ ;
DAVISON, AM .
NEPHRON, 1991, 59 (03) :461-465
[5]  
DAVENPORT A, 1989, NEPHROL DIAL TRANSPL, V4, P800
[6]   The use of different buffers during continuous hemofiltration in critically ill patients with acute renal failure [J].
Heering, P ;
Ivens, K ;
Thümer, O ;
Morgera, S ;
Heintzen, M ;
Passlick-Deetjen, J ;
Willers, R ;
Strauer, BE ;
Grabensee, B .
INTENSIVE CARE MEDICINE, 1999, 25 (11) :1244-1251
[7]   Dialytic therapy in acute renal failure: No reason for nihilism [J].
Himmelfarb, J .
SEMINARS IN DIALYSIS, 1996, 9 (03) :230-234
[8]   Effects of lactate-buffered and lactate-free dialysate in CAVHD patients with and without liver dysfunction [J].
McLean, AG ;
Davenport, A ;
Cox, D ;
Sweny, P .
KIDNEY INTERNATIONAL, 2000, 58 (04) :1765-1772
[9]  
ODETOLA F, 2004, CRIT CARE MED S, V32, pA86
[10]   EFFICACY OF CONTINUOUS ARTERIOVENOUS HEMOFILTRATION WITH DIALYSIS IN PATIENTS WITH RENAL-FAILURE [J].
REYNOLDS, HN ;
BORG, U ;
BELZBERG, H ;
WILES, CE .
CRITICAL CARE MEDICINE, 1991, 19 (11) :1387-1394